Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nagore Blanco Cid

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Asthma and Allergy|March 19, 2021
Phenotype-Guided Asthma Therapy: An Alternative Approach to GuidelinesLuis Pérez de Llano, David Dacal Rivas, Nagore Blanco Cid, et al.
Respiratory Medicine and Research|August 27, 2024
Diabetes mellitus with poor glycemic control is a risk factor for pneumonia in COPDRafael Golpe, Juan-Marco Figueira-Gonçalves, Laura Arias-Zas, et al.
Annals of Thoracic Medicine|November 17, 2022
Incidence and profile of severe exacerbations of chronic obstructive pulmonary disease due to biomass smoke or tobaccoRafael Golpe, Nagore Blanco-Cid, David Dacal-Rivas, et al.
Plos One|February 24, 2018
Validation of the portable Air-Smart SpirometerCristina Ramos Hernández, Marta Núñez Fernández, Abel Pallares Sanmartín, et al.
Archivos De Bronconeumologia|November 28, 2013
Clinical characteristics and survival in never smokers with lung cancerIsaura Parente Lamelas, José Abal Arca, Nagore Blanco Cid, et al.
The Clinical Respiratory Journal|June 22, 2022
Evaluation of the multimorbidity network and its relationship with clinical phenotypes in chronic obstructive pulmonary disease: The GALAXIA studyJuan Marco Figueira-Gonçalves, Rafael Golpe, Cristóbal Esteban, et al.
Journal of Investigational Allergology & Clinical Immunology|May 5, 2026
A Retrospective Multicenter Cohort Study on the Effectiveness of Triple Inhaled Therapy in Severe AsthmaDavid Dacal Rivas, Nagore Blanco Cid, Daniel Pérez Ortiz, et al.
Pulmonary Therapy|June 2, 2026
Real-World Outcomes across Baseline Risk Profiles in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights from the ORESTES StudyBernardino Alcázar-Navarrete, Juan Marco Figueira-Gonçalves, Nagore Blanco Cid, et al.
Respiratory Medicine|September 7, 2021
Efficacy of mepolizumab in usual clinical practice and characteristics of respondersCarlota Rodríguez-García, Marina Blanco-Aparicio, Juan José Nieto-Fontarigo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Asthma and Allergy|March 19, 2021
Phenotype-Guided Asthma Therapy: An Alternative Approach to GuidelinesLuis Pérez de Llano, David Dacal Rivas, Nagore Blanco Cid, et al.
Respiratory Medicine and Research|August 27, 2024
Diabetes mellitus with poor glycemic control is a risk factor for pneumonia in COPDRafael Golpe, Juan-Marco Figueira-Gonçalves, Laura Arias-Zas, et al.
Annals of Thoracic Medicine|November 17, 2022
Incidence and profile of severe exacerbations of chronic obstructive pulmonary disease due to biomass smoke or tobaccoRafael Golpe, Nagore Blanco-Cid, David Dacal-Rivas, et al.
Plos One|February 24, 2018
Validation of the portable Air-Smart SpirometerCristina Ramos Hernández, Marta Núñez Fernández, Abel Pallares Sanmartín, et al.
Archivos De Bronconeumologia|November 28, 2013
Clinical characteristics and survival in never smokers with lung cancerIsaura Parente Lamelas, José Abal Arca, Nagore Blanco Cid, et al.
The Clinical Respiratory Journal|June 22, 2022
Evaluation of the multimorbidity network and its relationship with clinical phenotypes in chronic obstructive pulmonary disease: The GALAXIA studyJuan Marco Figueira-Gonçalves, Rafael Golpe, Cristóbal Esteban, et al.
Journal of Investigational Allergology & Clinical Immunology|May 5, 2026
A Retrospective Multicenter Cohort Study on the Effectiveness of Triple Inhaled Therapy in Severe AsthmaDavid Dacal Rivas, Nagore Blanco Cid, Daniel Pérez Ortiz, et al.
Pulmonary Therapy|June 2, 2026
Real-World Outcomes across Baseline Risk Profiles in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate in Spain: Insights from the ORESTES StudyBernardino Alcázar-Navarrete, Juan Marco Figueira-Gonçalves, Nagore Blanco Cid, et al.
Respiratory Medicine|September 7, 2021
Efficacy of mepolizumab in usual clinical practice and characteristics of respondersCarlota Rodríguez-García, Marina Blanco-Aparicio, Juan José Nieto-Fontarigo, et al.
Pageof 1